This book offers a compelling ethical analysis of challenges in COVID-19 biomedical research, vaccination and therapy. Moreover, it draws attention to popular countermeasures, such as AI-based prevention, lockdowns and vaccinations. Through unique perspectives, it addresses some ethical challenges associated with the pandemic, providing ethical criteria guidelines for health emergencies, focusing on the allocation of limited life-saving resources in a triage situation and the dilemma of who to treat. In addition, the book highlights the necessity of the outlining of a global bioethical framework for pandemic management, rooted in human rights.
This book demonstrates that the COVID 19 pandemic asks for a a global approach to bioethics. it describes how the pandemic affects the experience of being in a world that is intrinsically characterized by global connectivity. It demonstrates that a moral vision is necessary to articulate this experience of connectedness. Subsequently, a perspective of global bioethics is introduced, which provides a broader framework than mainstream bioethics, since it highlights the significance of both vulnerability and solidarity. Through a unique global perspective the book addresses the moral challenges of the pandemic, and places the confrontation with death, disease and disability within a wider framework of ethical concerns. This book is of important in the public debate on infectious diseases, and of relevance to health professionals, global health educators, public health experts,as well as policy makers.
The COVID-19 pandemic has affected every human being on the planet and forced us all to reflect on the bioethical issues it raises. In this timely book, Gregory Pence examines a number of relevant issues, including the fair allocation of scarce medical resources, immunity passports, tradeoffs between protecting senior citizens and allowing children to flourish, discrimination against minorities and the disabled, and the myriad issues raised by vaccines.
This book offers a compelling ethical analysis of challenges in COVID-19 biomedical research, vaccination and therapy. Moreover, it draws attention to popular countermeasures, such as AI-based prevention, lockdowns and vaccinations. Through unique perspectives, it addresses some ethical challenges associated with the pandemic, providing ethical criteria guidelines for health emergencies, focusing on the allocation of limited life-saving resources in a triage situation and the dilemma of who to treat. In addition, the book highlights the necessity of the outlining of a global bioethical framework for pandemic management, rooted in human rights.
A portion of the revenue from this book’s sales will be donated to Doctors Without Borders to assist in the fight against COVID-19. The rapid spread of COVID-19 has had an unprecedented impact on modern health-care systems and has given rise to a number of complex ethical issues. This collection of readings and case studies offers an overview of some of the most pressing of these issues, such as the allocation of ventilators and other scarce resources, the curtailing of standard privacy measures for the sake of public health, and the potential obligations of health-care professionals to continue operating in dangerous work environments.
The Corona pandemic kills people, endangers families, friends, communities, companies, institutions, societies, economies and global networks. It brings about triage, unemployment, social distancing, and home schooling. Countries respond differently, often set aside civil and basic human rights. Families and friends cannot get together, visiting the sick, nor attending funerals. This pestilence is clearly a cultural, economic and political disease. 40 leaders in medical and sociological research, in politics, religion, and consulting from 24 countries offer diverse, sometimes controversial answers, collected by Martin Woesler and Hans-Martin Sass .
This book addresses the many ethical issues and extraordinary risks that nurses and others are facing during the COVID-19 pandemic, which creates physical, emotional, and economic burdens, affecting nurses' overall health and well-being. Nurses are essential front-line clinicians across all health care settings and in every nation. The COVID-19 pandemic caused by the novel SARs-CoV-2 virus has affected children, adults, and communities within and across all societies. Nurses, too, have contracted the virus and died from the disease. They have also seen their colleagues, family members, and friends hospitalized or in intensive care units struggling to survive. Nursing’s professionalism and disciplinary resolve to care for patients and families amidst confusion, misinformation, and shifting guidelines has been called “heroic” by the public. How much risk should nurses be expected to accept during a pandemic? How do nurses help patients and families find comfort and dignity at the end-of-life? How do we help nurses who are suffering from moral distress and mental health concerns from what they have seen, been asked to do, or are unable to provide? And, how does society move forward from a pandemic that has challenged our basic ethical principles of justice and what is “fair, good and right” in caring for those who need care, including the most vulnerable and nurses themselves? This book addresses these and other ethical concerns that nurses are facing in their day-to-day clinical practice; experiences shared with patients, families, and colleagues. Although this book was written while the pandemic was still raging across the United States and globally, the events needed to be told as they were unfolding. This book helps us to learn from both the successes and failures that are affecting so many across the globe, including those on whom the public relies on to provide quality, compassionate, and expert care when they are sick: nurses.
As nations race to hone contact-tracing efforts, the world's experts consider strategies for maximum transparency and impact. As public health professionals around the world work tirelessly to respond to the COVID-19 pandemic, it is clear that traditional methods of contact tracing need to be augmented in order to help address a public health crisis of unprecedented scope. Innovators worldwide are racing to develop and implement novel public-facing technology solutions, including digital contact tracing technology. These technological products may aid public health surveillance and containment strategies for this pandemic and become part of the larger toolbox for future infectious outbreak prevention and control. As technology evolves in an effort to meet our current moment, Johns Hopkins Project on Ethics and Governance of Digital Contact Tracing Technologies—a rapid research and expert consensus group effort led by Dr. Jeffrey P. Kahn of the Johns Hopkins Berman Institute of Bioethics in collaboration with the university's Center for Health Security—carried out an in-depth analysis of the technology and the issues it raises. Drawing on this analysis, they produced a report that includes detailed recommendations for technology companies, policymakers, institutions, employers, and the public. The project brings together perspectives from bioethics, health security, public health, technology development, engineering, public policy, and law to wrestle with the complex interactions of the many facets of the technology and its applications. This team of experts from Johns Hopkins University and other world-renowned institutions has crafted clear and detailed guidelines to help manage the creation, implementation, and application of digital contact tracing. Digital Contact Tracing for Pandemic Response is the essential resource for this fast-moving crisis. Contributors: Joseph Ali, JD; Anne Barnhill, PhD; Anita Cicero, JD; Katelyn Esmonde, PhD; Amelia Hood, MA; Brian Hutler, Phd, JD; Jeffrey P. Kahn, PhD, MPH; Alan Regenberg, MBE; Crystal Watson, DrPH, MPH; Matthew Watson; Robert Califf, MD, MACC; Ruth Faden, PhD, MPH; Divya Hosangadi, MSPH; Nancy Kass, ScD; Alain Labrique, PhD, MHS, MS; Deven McGraw, JD, MPH, LLM; Michelle Mello, JD, PhD; Michael Parker, BEd (Hons), MA, PhD; Stephen Ruckman, JD, MSc, MAR; Lainie Rutkow, JD, MPH, PhD; Josh Sharfstein, MD; Jeremy Sugarman, MD, MPH, MA; Eric Toner, MD; Mar Trotochaud, MSPH; Effy Vayena, PhD; Tal Zarsky, JSD, LLM, LLB
